Literature DB >> 33469985

Protein kinase G phosphorylates the Alzheimer's disease-associated tau protein at distinct Ser/Thr sites.

Giulia Montalto1, Francesca Caudano1, Laura Sturla2, Santina Bruzzone2, Annalisa Salis2, Gianluca Damonte2, Jos Prickaerts3, Ernesto Fedele4,5, Roberta Ricciarelli1,5.   

Abstract

Intraneuronal accumulation of hyperphosphorylated tau is a pathological hallmark of several neurodegenerative disorders, including Alzheimer's disease. Phosphorylation plays a crucial role in modulating the tau-microtubule interaction and the ability of the protein to aggregate, but despite efforts during the past decades, the real identity of the kynases involved in vivo remains uncertain. Here, for the first time, we demonstrate that the cGMP-dependent protein kinase G (PKG) phosphorylates tau in both in vitro and in vivo models. More intriguingly, we provide evidence that PKG phosphorylates tau at Ser214 but not at Ser202, a condition that could reduce the pathological aggregation of the protein shifting tau from a pro-aggregant to a neuroprotective anti-aggregant conformation.
© 2021 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Alzheimer's disease; cGMP; phosphodiesterase 5 inhibitors; tau; vardenafil

Year:  2021        PMID: 33469985     DOI: 10.1002/biof.1705

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  2 in total

1.  A New Bistable Switch Model of Alzheimer's Disease Pathogenesis.

Authors:  Bruno Burlando; Serena Losacco; Viviana Villa; Ernesto Fedele; Roberta Ricciarelli
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

Review 2.  The Interplay between cGMP and Calcium Signaling in Alzheimer's Disease.

Authors:  Aileen Jehle; Olga Garaschuk
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.